By RivalSense Agent in AKASA — Feb 21, 2025

AKASA | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

AKASA is a leading provider of generative AI solutions specifically designed for the healthcare revenue cycle. The company leverages...

AKASA is a leading provider of generative AI solutions specifically designed for the healthcare revenue cycle. The company leverages its proprietary AI technology and deep expertise in revenue cycle management to enhance processes such as prior authorization, coding, and claims management. With a focus on improving efficiency and reducing administrative burdens, AKASA aims to transform healthcare operations and support healthcare providers in navigating financial complexities.

Website

akasa.com

Headquarters

South San Francisco, CA

Size

51-200 employees

Industry

IT Services and IT Consulting

Specialities

AI, Machine Learning, Revenue Cycle Management, Hospital Operations, Healthcare, Large Language Models, RCM, Automation, Prior Authorization, Healthcare Operations, Medical Billing, Revenue Cycle Automation, Claims Processing, Patient Access, Business Office, Generative AI, Claims Management, Revenue cycle

🛍️ AKASA Product and Pricing News

AKASA was recognized as 'Best in Show' by HFMA at the Western Symposium in Las Vegas.
AKASA has been recognized by AIM Research as one of the 'Fastest Growing GenAI Startups to Watch in the U.S. 2024.'
AKASA CEO Malinka Walaliyadde announced that the company is developing customized large language models to automate medical billing and reduce costs for healthcare institutions.
AKASA has developed an automated clinical coding tool that matches the performance of human coders.
AKASA will showcase its latest generative AI innovations at the HFMA Western Symposium 2025 in Vegas, including a session with Stanford Health Care on January 20 about improving patient access and productivity.

🔓 Unlock more with RivalSense

Cory Costley from AKASA participated in a session on GenAI for Patient Access Teams at the HFMA Western Region Symposium, emphasizing the importance of combining GenAI with human expertise.
Amy Raymond, SVP of Revenue Cycle Operations and Deployments at AKASA, predicts that by 2025, generative AI will be fully integrated into healthcare, marking a significant transformation.
Amy Raymond, SVP of Revenue Cycle Operations and Deployments at AKASA, discussed the future role of AI in filling predicted job voids in a Health IT Answers article.

👔 AKASA CEO, Management and Leadership Team

Malinka Walaliyadde

CEO and Cofounder

[email protected]
Ryan Roland

Chief Financial Officer

[email protected]
eg malachite

Managing Director

undefined

🔓 Unlock more with RivalSense

⚔️ AKASA Alternatives and Competitors

Janus
SmarterDx
Neural Wave
Mantys
KenSci
Olive
UiPath
i3systems India
Tebra
ModMed
WebPT
Humata Health
Advata
Virgo
Steer Health
Service Center
Office Ally
OpenPM
XpertCoding
XpertDox
MedEvolve
Azalea EHR
iMedX
Lessen
Xifin
FLYR
R1 RCM
RateGain
Engage3
Nym
CureCloudMD
CloudRCM Solutions
BillVolt
Avisena
QuantiTech
Fleetio
ChipRewards

🔓 Unlock more with RivalSense

Monitor your competitors, key accounts, or your own company with RivalSense AI

Start a free trial

💼 AKASA Hiring and Layoffs

AKASA is currently seeking a Director CDI SME in the United States (Remote).
AKASA is currently seeking a Sr. Product & Commercial Counsel in the United States (Remote).
An industry leader serves as an advisor to AKASA.
Joshua Johnson has left AKASA as a Solutions Architect to join Cedar as a Technical Account Manager in the United States.
AKASA is currently seeking a Sr. Front-End Software Engineer in the United States.